Cargando…
Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease
The oral antidiabetic drug metformin is known to exhibit anti-inflammatory properties through activation of AMP kinase, thus protecting various brain tissues as cortical neurons, for example. However, the effect of metformin on the substantia nigra (SN), the main structure affected in Parkinson’s di...
Autores principales: | Tayara, Khadija, Espinosa-Oliva, Ana M., García-Domínguez, Irene, Ismaiel, Afrah Abdul, Boza-Serrano, Antonio, Deierborg, Tomas, Machado, Alberto, Herrera, Antonio J., Venero, José L., de Pablos, Rocío M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258993/ https://www.ncbi.nlm.nih.gov/pubmed/30519161 http://dx.doi.org/10.3389/fncel.2018.00440 |
Ejemplares similares
-
Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration
por: García-Revilla, Juan, et al.
Publicado: (2022) -
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
por: Garcia-Revilla, Juan, et al.
Publicado: (2020) -
Inflammatory Animal Models of Parkinson’s Disease
por: García-Revilla, Juan, et al.
Publicado: (2022) -
Relevance of chronic stress and the two faces of microglia in Parkinson’s disease
por: Herrera, Antonio J., et al.
Publicado: (2015) -
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
por: García-Revilla, Juan, et al.
Publicado: (2023)